Rethinking diet and the gut microbiome in IBD: from risk to treatment and beyond
28 May 2026by GMFH Editing Team
The role of diet and the gut microbiome in inflammatory bowel disease (IBD) continues to evolve, from shaping disease risk to supporting treatment strategies. In this interview with Richard Hansen and Chen Sarbagili, we discuss key misconceptions, emerging evidence, and what the future may hold for microbiome-based approaches in IBD.
Patrick Veiga is a Research Director specializing in gut microbiota and its links with nutrition and health. He is the Scientific Director of the Le French Gut project and of MetaGenoPolis, the lab coordinating it. He also serves as a board member of the Pharmabiotic Research Institute. Throughout his career, he has worked in both academia and industry, including as a visiting researcher at Harvard University. His expertise spans gut microbiota research, nutrition, probiotics, and the emerging field of precision nutrition.